Can of worms [Regulatives / Guidelines]

posted by jag009  – NJ, 2020-02-03 20:28 (440 d 21:17 ago) – Posting: # 21134
Views: 2,409

Hi ElMastro,

» Try and discuss the case with different CROs, I think you find that several of them (in EU their numbers are limited) have been in situation before and have been discussing the matter with other sponsors + authorities as well as with IECs.

Well my predecessor ran the IR SS study (over the total daily dose) many years ago and she ran it in UK. Not sure if she explored many European countries. She didn't do in US due to need for IND.

» What are you actually going to measure? :-)

You mean what fluid? Blood and Urine sampling. Will measure parent and metabolites, and something new (some sort of marker) if the analytical method of interest is available (to be confirmed) :-D

Thx
J

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 9 (0 registered, 9 guests [including 2 identified bots]).
Forum time: Monday 18:45 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5